# A Patient Handling Study of Mometasone Furoate/Formortoral Fumarate (MF/F) Metered Dose Inhaler (MDI) With an Integrated Dose Counter in Adolescent and Adult Subjects With Asthma or Chronic Obstructive Pulmonary Disease (Study P04703AM1)

> **NCT00604500** · PHASE3 · COMPLETED · sponsor: **Organon and Co** · enrollment: 272 (actual)

## Conditions studied

- Asthma
- COPD

## Interventions

- **DRUG:** SCH No. 418131 (Mometasone Furoate/Formoterol Furoate abbreviated MF/F )

## Key facts

- **NCT ID:** NCT00604500
- **Lead sponsor:** Organon and Co
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-03-01
- **Primary completion:** 2008-11-01
- **Final completion:** 2008-11-01
- **Target enrollment:** 272 (ACTUAL)
- **Last updated:** 2024-05-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00604500

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00604500, "A Patient Handling Study of Mometasone Furoate/Formortoral Fumarate (MF/F) Metered Dose Inhaler (MDI) With an Integrated Dose Counter in Adolescent and Adult Subjects With Asthma or Chronic Obstructive Pulmonary Disease (Study P04703AM1)". Retrieved via AI Analytics 2026-09-14 from https://api.ai-analytics.org/clinical/NCT00604500. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*